Kiel Nano, Surface and Interface Science (KiNSIS)

Future promises of translational liposomal nanoparticles in cancer (Prof. Alberto A Gabizon, Jerusalem)

16.04.2018 ab 15:00

Institut für Experimentelle Tumorforschung (IET) Arnold-Heller-Str. 3, Haus 17, Raum 317

Professor Gabizon is one of the world leaders in translational liposomal nanoparticles and renowned scientist and clinician in the field of nanomedicine and cancer therapy. As co-inventor and co-developer of Doxil® and Promitil®, Prof. Gabizon was key for the successful development and clinical implementation of liposomal drugs. He serves as Member of Scientific Advisory Board at Cristal Therapeutics BV. He serves as Professor of Oncology. He serves as Chairman at Shaare Zedek Medical Center, of The Hebrew University of Jerusalem.

Please register with Oula Peñate Medina oula.penate@rad.uni-kiel.de

Diesen Termin meinem iCal-Kalender hinzufügen

zurück

Pressemitteilungen

Aktuelles

Veranstaltungen

Kalender

« März 2019 »
Mo Di Mi Do Fr Sa So
25 26 27 28 1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31